Home » Newsletters » BioWorld

BioWorld

March 26, 1992

View Archived Issues

CHEMIX REVERSE STOCK SPLIT

EVANS-FREKE VENTURE RAISES $6M

CELLPRO ADDS NEW CEPRATE KITS

CORVAS SBIR FOR DRUG DESIGN STUDY

DNAP TO TRIPLE JOINT VENTURE REVENUE

ANOTHER IPO SUFFERS IN SOFT MARKET

PHASE III BEGINS ON ELECTRIC SHOCK ADJUNCT

MERGING COMPANIES LINE UP ANOTHER DEAL

BAXTER BUYS STAKE IN AIDS VACCINE DEVELOPER